The European Commission (EC) has granted marketing authorization for Meda's Zyclara (imiquimod 3.75% cream) for the treatment of actinic keratosis (AK), in the European Union. Zyclara can detect and eliminate subclinical as well as ...
Tags: Meda Zyclara, actinic keratosis, clinical AK lesions, Skin cancer